Development of an orally active tripeptide arginal thrombin inhibitor.
Shuman
R T
RT
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Gesellchen
P D
PD
D000284:Administration, Oral; D000818:Animals; D000991:Antithrombins / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D009842:Oligopeptides / Q000493:pharmacokinetics / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D000991:Antithrombins; D009842:Oligopeptides; C064289:efegatran